title: Transcriptional and epigenetic regulation of KIAA1199 gene expression in human breast cancer.
abstract: Emerging evidence has demonstrated that upregulated expression of KIAA1199 in human cancer bodes for poor survival. The regulatory mechanism controlling KIAA1199 expression in cancer remains to be characterized. In the present study, we have isolated and characterized the human KIAA1199 promoter in terms of regulation of KIAA1199 gene expression. A 3.3 kb fragment of human genomic DNA containing the 5'-flanking sequence of the KIAA1199 gene possesses both suppressive and activating elements. Employing a deletion mutagenesis approach, a 1.4 kb proximal region was defined as the basic KIAA1199 promoter containing a TATA-box close to the transcription start site. A combination of 5'-primer extension study with 5'RACE DNA sequencing analysis revealed one major transcription start site that is utilized in the human KIAA1199 gene. Bioinformatics analysis suggested that the 1.4 kb KIAA1199 promoter contains putative activating regulatory elements, including activator protein-1(AP-1), Twist-1, and NF-κB sites. Sequential deletion and site-direct mutagenesis analysis demonstrated that the AP-1 and distal NF-κB sites are required for KIAA1199 gene expression. Further analyses using an electrophoretic mobility-shift assay and chromatin immunoprecipitation confirmed the requirement of these cis- and trans-acting elements in controlling KIAA1199 gene expression. Finally, we found that upregulated KIAA1199 expression in human breast cancer specimens correlated with hypomethylation of the regulatory region. Involvement of DNA methylation in regulation of KIAA1199 expression was recapitulated in human breast cancer cell lines. Taken together, our study unraveled the regulatory mechanisms controlling KIAA1199 gene expression in human cancer.
authors.affiliation: Department of Medicine/Cancer Prevention, Stony Brook University, Stony Brook, New York, United States of America.
authors.forename: Cem
authors.initials: C
authors.lastname: Kuscu
authors.forename: Nikki
authors.initials: N
authors.lastname: Evensen
authors.forename: Deborah
authors.initials: D
authors.lastname: Kim
authors.forename: You-Jun
authors.initials: YJ
authors.lastname: Hu
authors.forename: Stanley
authors.initials: S
authors.lastname: Zucker
authors.forename: Jian
authors.initials: J
authors.lastname: Cao
mesh_terms: D001483:Base Sequence; D001943:Breast Neoplasms / Q000235:genetics*; D004247:DNA; D044127:Epigenesis, Genetic; D005260:Female; D020868:Gene Silencing; D006801:Humans; D006821:Hyaluronoglucosaminidase; D008969:Molecular Sequence Data; D011401:Promoter Regions, Genetic; D011506:Proteins / Q000235:genetics*; D060888:Real-Time Polymerase Chain Reaction; D012689:Sequence Homology, Nucleic Acid; D014158:Transcription, Genetic
chemical_list: D011506:Proteins; D004247:DNA; C491433:CEMIP protein, human; D006821:Hyaluronoglucosaminidase